XML 34 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Research and Development Arrangements and Related Party Transactions (Details) (USD $)
12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended 1 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Jun. 30, 2012
Non- Bioral [Member]
Dec. 31, 2012
Accentia Biopharmaceuticals, Inc [Member]
Employee
Dec. 31, 2011
Accentia Biopharmaceuticals, Inc [Member]
Dec. 31, 2010
Accentia Biopharmaceuticals, Inc [Member]
Dec. 31, 2009
Accentia Biopharmaceuticals, Inc [Member]
Dec. 31, 2012
Emezine Settlement Agreement [Member]
Dec. 31, 2011
Emezine Settlement Agreement [Member]
Dec. 31, 2009
Emezine Settlement Agreement [Member]
Jun. 30, 2012
Bioral [Member]
Related Party Transactions (Textual) [Abstract]                        
Consideration percentage of future potential revenues from related party       3.50%               10.00%
Number of employee shared for accounting and administrative staff         1              
Payments for Rent         $ 60,000 $ 60,000 $ 60,000          
Shares of common stock of Biovest International, Inc. 281,865 601,120                 2,000,000  
Derivative Gain (5,594,152) 3,463,453 3,126,771           300,000      
Derivative loss                   $ 900,000    
Warrant exercise price               0.84